Full-Time
Quality Engineer 2
Posted on 6/13/2026
Elsevier
10,001+ employees
Global STM publisher of journals.
No salary listed
Bengaluru, Karnataka, India
In Person
 QA & Testing |
|---|
- 2-4 years of QA/QE experience with manual and automation testing
- BS in Engineering, Computer Science, or equivalent practical experience
- Experience in data-intensive or analytics-driven environments preferred
- Test automation using Playwright with TypeScript or Java
- CI/CD pipelines, particularly GitHub Actions
- JIRA and Confluence for issue tracking and documentation
- Data pipeline concepts and data quality testing methodologies
- UI dashboard testing for data health and accuracy
- Strong attention to detail and documentation skills
- Design and execute manual and automated test cases for data pipelines and UI dashboards
- Validate data quality metrics, pipeline outputs, and dashboard health indicators
- Collaborate with Data Engineering and Product/UX to define acceptance criteria and quality standards
- Build and maintain automated test suites using Playwright with TypeScript/Java in GitHub Actions
- Participate in defect tracking, root cause analysis, and continuous improvement initiatives
- Maintain test plans, test cases, and QA process documentation in Confluence
- Support internal and external audits by maintaining records and framework documentation
- All other duties as assigned
Elsevier provides scientific, medical, and technical content and analytics to researchers, educators, clinicians, and institutions worldwide through journals, books, databases, and digital platforms. It operates by offering access to peer-reviewed articles and professional literature via online platforms, along with tools for discovery, citation tracking, research management, and clinical decision support. Unlike other publishers, Elsevier combines a broad portfolio of STM content with integrated analytics and workflow tools, serving researchers, healthcare professionals, and academic institutions on a global scale. Its goal is to enable the advancement of knowledge and improve health outcomes by delivering reliable, accessible information and data-driven solutions across the research lifecycle.
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
Amsterdam, Netherlands
Founded
1880
Your Connections
People at Elsevier who can refer or advise you
Simplify's Take
What believers are saying
- ClinicalKey AI already serves more than 300 hospitals worldwide.
- Workflow integration reduces adoption friction for governed AI in care settings.
- Universities UK partnership deepens Elsevier's research analytics role in IS-8 sectors.
What critics are saying
- Open-access mandates continue eroding subscription pricing and renewal leverage.
- Epic-native and hospital-owned tools can displace ClinicalKey AI at the bedside.
- VR education products face budget pressure from cheaper simulation vendors.
What makes Elsevier unique
- Elsevier combines peer-reviewed content with workflow-integrated clinical decision support.
- Shadow Health Lab adds 165+ simulations and 30 VR patient encounters.
- Wellsheet extends ClinicalKey AI into EHR workflows across 139 hospitals.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Unlimited Paid Time Off
Flexible Work Hours
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Employee Assistance Program
Short-and-Long Term Disability
Life Insurance
Accidental Death Insurance
Wellness Program
Family Planning Benefits
Fertility Treatment Support
Health Savings Account/Flexible Spending Account
Company News
2025 CiteScore released: Open Exploration journals reach new heights in academic impact. Jun. 5, 2026 683 On June 3, 2026, Elsevier officially released the 2025 CiteScore data. As one of the core metrics for measuring journal academic impact in the international academic community, the annual update of CiteScore objectively reflects the academic dissemination capability and disciplinary development level of journals in recent years. This year, a total of 5 Open Exploration journals indexed in Scopus have demonstrated outstanding performance, with multiple indicators showing upward trends. Among them, Exploration of Medicine (EM) and Exploration of Targeted Anti-tumor Therapy (ETAT) both ranked in the Q2 quartile in their respective disciplines. EM has achieved significant improvements in both score and ranking, while ETAT has entered the Q2 quartile in oncology for the first time, achieving an annual increase of 74.19% in its score, rising to 5.4. Exploration of Immunology (EI) and Exploration of Neuroprotective Therapy (ENT) have both maintained consecutive year-over-year growth, demonstrating their development potential in their respective fields. The newly indexed journal Exploration of Foods and Foodomics (EFF) has received its first CiteScore of 2.4, marking a significant milestone. Below is the detailed information of the CiteScores for 5 journals. Exploration of Medicine (EM) The 2025 CiteScore of Exploration of Medicine rose to 2.9, a year-on-year increase of 61.11% from 1.8 in 2024, maintaining its Q2 position in General Medicine. Ranked 207th among 669 journals in the field, EM climbed 60 places compared to the previous year, reflecting substantial improvements in citation levels and overall academic quality. The journal focuses on innovative clinical and basic medical research in general medicine and is now indexed in authoritative databases including Scopus, Google Scholar, DOAJ, and CAS. Welcome to submit at: https://em.aressystem.com/. Exploration of Targeted Anti-tumor Therapy (ETAT) The 2025 CiteScore of Exploration of Targeted Anti-tumor Therapy reached 5.4, an impressive 74.19% increase from the previous year. For the first time, ETAT entered the Q2 quartile in Oncology, ranking 140th among 428 journals in the field - a breakthrough development. The journal focuses on frontiers of targeted therapy and clinical translational research, and is indexed in Scopus, PubMed/PMC, Google Scholar, and other authoritative databases. ETAT's CiteScore has maintained continuous growth for four consecutive years (1.7 in 2022 | 2.8 in 2023 | 3.1 in 2024 | 5.4 in 2025), steadily enhancing its academic influence with sustained support from its editorial board, reviewers, and authors. Welcome to submit at: https://etat.aressystem.com. Exploration of Immunology (EI) The 2025 CiteScore of Exploration of Immunology increased to 1.9, achieving consecutive annual growth (1.0 in 2023 | 1.5 in 2024 | 1.9 in 2025). This upward trend indicates continuous improvement in the journal's academic quality and reader engagement, highlighting its development potential in the field of immunology. EI focuses on fundamental immunology and mechanisms of immune diseases, publishing high-quality academic outputs, and is indexed in Scopus, Google Scholar, DOAJ, CAS, and other major databases. Welcome to submit at: https://ei.aressystem.com. Exploration of Neuroprotective Therapy (ENT) The 2025 CiteScore of Exploration of Neuroprotective Therapy rose to 2.6, a 30% increase from 2.0 in 2024. ENT specializes in neurodegenerative diseases, neuroprotection, and neurorestoration, with a precise academic focus and rigorous review standards. Indexed in Scopus, Google Scholar, DOAJ, CAS, and other mainstream databases, ENT's academic influence in neuroscience continues to grow steadily. The journal will remain committed to publishing cutting-edge research in neuroprotection and providing a high-quality communication platform for scholars. Welcome to submit at: https://ent.aressystem.com. Exploration of Foods and Foodomics (EFF) Exploration of Foods and Foodomics was indexed in Scopus in June 2025 and received its first-ever CiteScore of 2.4 in this release - a solid foundation for future growth. This milestone recognizes the journal's publication quality, topic value, and academic standards, which have been acknowledged by an internationally authoritative platform. EFF focuses on the interdisciplinary frontiers of food science and foodomics, contributing to academic innovation and translational outcomes in the food field. It is currently indexed in Scopus, Google Scholar, DOAJ, CAS, and other major databases, with its international academic influence steadily rising. Welcome to submit at: https://eff.aressystem.com. About the 2025 CiteScore The CiteScore metric is calculated by dividing the total citations received by all documents published in a journal over a four-year period (including research articles, review articles, conference papers, data papers, and book chapters) by the total number of such documents published during the same period. The 2025 CiteScore covers the citation window from 2022 to 2025. As an important reference for measuring journal academic impact, CiteScore provides an intuitive reflection of a journal's sustained academic contribution and literature dissemination efficiency, while also offering an objective basis for scholars to select journals for submission, track disciplinary hotspots, and evaluate the academic value of research outputs. Advancing Scholarship, Embracing the Future The achievements of Open Exploration journals in this year's CiteScore release would not have been possible without the professional support and collective efforts of the editorial board members, peer reviewers, and author community. Moving forward, Open Exploration will continue to uphold rigorous peer review mechanisms, adhere to principles of academic integrity in publishing, further optimize manuscript processing workflows, and enhance the author service experience. Open Exploration Publishing Inc. remain committed to publishing high-quality academic achievements, continuously improving its publishing standards and international academic influence. Open Exploration looks forward to collaborating with more researchers to promote the broad dissemination and sharing of academic achievements.
Elsevier has been recognized among India's top 50 best workplaces(tm) in health & wellness 2026: companies that care by great place to work(r). April 10, 2026 We're pleased to share that Elsevier has been recognized among India's top 50 best workplaces(tm) in health & wellness 2026: companies that care by great place to work(r). This recognition is based on insights from over 170,000 employees across 260+ organizations in India, and it reinforces something we deeply believe, when people feel supported, they do their best work. At Elsevier, we remain committed to creating a workplace where wellbeing is prioritized. A big thank you to our people who make this wellness and well-being culture possible every day.
Colorado SunFest 2026 panel: exploring 150 years of statehood. History Colorado will join Colorado SunFest 2026 to discuss the state's history and how it's been told and shaped The Colorado Sun 9:22 AM MDT on Mar 31, 2026Updated 4:52 PM MDT on Apr 2, 2026 Colorado SunFest 2026 is a daylong event bringing Coloradans together to discuss what makes A Better Colorado. Find out more about specific sessions planned for Friday, May 1, below. Panel Name: Colorado Turns 150 On Aug. 1, Colorado will mark its 150th year of statehood, and to celebrate, The Colorado Sun is working on a series called Colorado 150, a curated list of 150 things that make the state colorful. The conversation, as part of the celebration, will look into the state's history and how it's been told and shaped. While Colorado is working to broaden its history, the federal government is working to narrow it. Panelists Jason Hanson, chief creative officer and director of interpretation & research at History Colorado, and Annie Levinsky, vice president of History Colorado, will explore Colorado's history and the current "heritage audit" going on at History Colorado. Jason Hanson, chief creative officer and director of interpretation & research at History Colorado. Hanson has worked for History Colorado since 2016, serving as the chief creative officer of interpretation and research, as well as the deputy state historian. In his role, he works closely with the Colorado State Historian's Council as the deputy state historian, and is a member of the state's American 250-Colorado 150 Commission. Previously, Hanson has served as research faculty for the University of Colorado's Center of the American West in Boulder, and a production editor for Elsevier Publishing. His most recent book, "Brewed at Altitude: A Beer Lover's History of Colorado," with Sam Bock, was recently published to mark 150 years as the Centennial State. He received his Master of Arts in City/Urban, Community and Regional Planning from the University of Colorado-Denver and his Master of Arts in History from the University of Colorado-Boulder. Annie Levinsky, vice president of History Colorado. Levinsky is leading the Heritage for All project, a part of the Colorado 150th celebration and the country's 250th celebration, the project aims to change the way community preservation is viewed. Previously, she served as executive director for Historic Denver, Inc. for more than 12 years, and worked at the Molly Brown House Museum, located in Denver and owned by Historic Denver - for more than six years. Levinsky received her degree from Colorado College. The panel, "Colorado turns 150" is one of 11 conversations scheduled for Colorado SunFest 2026. The fourth annual Colorado SunFest is Friday, May 1, at Josef Korbel School of Global and Public Affairs on the University of Denver campus. Tickets for the event are available on The Colorado SunFest event page. Other Colorado SunFest sessions. Type of story: behind the story. Clarifies for the public how a story was reported.
NCPDP appoints Julia Vu, PharmD, as EVP of Public Policy and Professional Relations. Up next. Published on 24 March 2026 New leadership role aims to enhance healthcare policy initiatives. * Julia Vu joins NCPDP as Executive Vice President. * Focused on advancing healthcare policy initiatives. * Experience includes previous leadership role at Elsevier. The National Council for Prescription Drug Programs (NCPDP) has appointed Julia Vu, PharmD, as the new Executive Vice President of Public Policy and Professional Relations. In this role, Vu will focus on advancing healthcare policies and initiatives while enhancing the organization's influence within the industry. Her extensive background in the healthcare sector positions her to address the evolving landscape of pharmacy services and medication management. Before joining NCPDP, Vu served as Vice President at Elsevier, where she led various strategic initiatives relevant to healthcare delivery and medication optimization. Her experience in public policy and pharmacy practice will support NCPDP's mission to improve health outcomes through effective advocacy and stakeholder engagement. This appointment comes at a crucial time as NCPDP continues to adapt to new challenges and opportunities in the healthcare system. Vu's experience also includes time spent in regulatory affairs and stakeholder collaboration, which will be instrumental as NCPDP engages with diverse healthcare professionals and policy-makers. As the organization looks to strengthen its role in the healthcare industry, Vu's leadership is expected to bring a fresh perspective to the ongoing dialogue on critical pharmacy and medication-related issues. You may also like. Services PMI at 53.8 in january 2026, according to ISM report. January sees strong growth in services sector as PMI remains robust. Services... * February 4, 2026 Pharmacelera raises $6M to expand in US and enhance drug discovery platform. Funding will support growth and technological advancements in drug discovery. Pharmacelera has... * February 18, 2026 BD helps scientists advance immunology and cancer research with ai-powered insights and automation. Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research... NUNM receives $1.5 million gift to support campus expansion and future integrative medicine center. Major donation aims to enhance educational opportunities at NUNM. NUNM receives a... * February 28, 2026
Elsevier named among large businesses worldwide as an established workplace leader. March 23, 2026 Financial Times: Comparably Announces 2026 Best Company Outlook, Companies for Women, and Companies for Diversity Awards. Elsevier Ranked #1 for Diversity and Top 2 for Women and Outlook. ADP, Elsevier, Adobe, Workday, and Calix lead 2026 rankings as employee sentiment highlights emerging and established workplace leaders VANCOUVER, Wash.-(BUSINESS WIRE)-Mar. 10, 2026- Comparably (a ZoomInfo company), a leading employee review platform for workplace culture and compensation, announced the winners of its 2026 Best Company Outlook, Best Companies for Women, and Best Companies for Diversity Awards. The awards highlight organizations that employees rate highest across nearly 20 core culture metrics - including future business confidence, eNPS, compensation, career growth, leadership, and work environment. Elsevier defended its #1 position for Best Companies for Diversity for the second consecutive year, continuing to set the benchmark for inclusive workplaces according to employees of color. 2026 Best Company Outlook (Large Companies): * Calix * Elsevier * TP * GE Vernova * ADP 2026 Best Companies for Women (Large Companies): * ADP * Elsevier * Workday * Microsoft * NUCOR CORPORATION 2026 Best Companies for Diversity (Large Companies): * Elsevier * Adobe * Nvidia * Baylor Scott & White Health 5. ADP Read more: https://bit.ly/4bstxMG